Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license
NOTCH4 · rs3134942
Stands on its own. Nothing else here links to this position yet — but the page above is the point: what the research found, what each genotype means, and where it came from, in language you can read. Links to conditions, drugs and the senses appear automatically if we write them.
Strength of the evidence
Its strongest genetic-study result is p = 10−16, with 3 associations in the GWAS Catalog.
4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.
What the study found
Who was studied 997 European ancestry individuals; replicated in 338 Greater Middle Eastern (Middle Eastern, North African or Persian), South Asian ancestry, Asian ancestry individuals.
The effect Each copy of the T allele shifted the measure 0.579 higher (95% confidence interval 0.44-0.71); p = 1 × 10−16.
Where it sits Chromosome 6, band 6p21.32 — a synonymous change in NOTCH4.
What ClinVar records
Classification
Benign for Cholangiocarcinoma, Uterine carcinosarcoma, Thymoma, Adrenocortical carcinoma, hereditary; criteria provided, single submitter (1 of 4 stars, 2 submitters), last evaluated 2021-05-04.
ClinVar record 1259043 NM_004557.4(NOTCH4):c.4152C>A (p.Val1384=)
Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.
What this is ClinVar's aggregate record for this position (as of its 2026-11-09 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.
How common each version is
GT
G 94.1% · T 5.9%
G 94.5% · T 5.5%
G 99.7% · T 0.3%
G 98.1% · T 1.9%
G 89.4% · T 10.6%
G 92.2% · T 7.8%
G 89.9% · T 10.1%
By ancestry gnomAD
G 97.2% · T 2.8%
G 86.7% · T 13.3%
G 90.9% · T 9.1%
G 90.6% · T 9.4%
G 94.6% · T 5.4%
G 94.9% · T 5.1%
G 88.3% · T 11.7%
G 92.3% · T 7.7%
The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.
Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license
MHC class I polypeptide-related sequence A levels (rs3134942). MyGeneLog™. https://www.mygenelog.com/variants/rs3134942